Showing results (331-340 of 470) with videos related to

Sort By:
Pageof 47
Frontiers in Plant Science|June 27, 2017
Variable Level of Dominance of Candidate Genes Controlling Drought Functional Traits in Maize HybridsHa Van Gioi, Mallana Gowdra Mallikarjuna, Mittal Shikha, et al.
Basic & Clinical Pharmacology & Toxicology|July 7, 2011
Neutralization of haemorrhagic activity of viper venoms by 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-3-oxo-1,3-dihydroisobenzofuran-5-carbonitrileKabburalli Sunitha, Mahadevappa Hemshekhar, Santosh Laxman Gaonkar, et al.
Heart Views : the Official Journal of the Gulf Heart Association|June 21, 2014
Short term efficacy and safety of low dose tolvaptan in patients with acute decompensated heart failure with hyponatremia: a prospective observational pilot study from a single center in South IndiaSoumya Patra, Basant Kumar, Kaushal K Harlalka, et al.
Current Drug Targets|January 9, 2026
Targeting STAT3 in Breast Cancer Using Innovative Natural and Synthetic Scaffolds to Trigger Apoptosis, Autophagy, and Halt Tumor ProgressionBhavana Jayadevappa, Dhanya Dinesh, Allaka Nagalakshmi, et al.
Journal of Neuroendocrinology|November 10, 2023
Gene deletion of the PACAP/VIP receptor, VPAC2R, alters glycemic responses during metabolic and psychogenic stress in adult female miceElena V Kozlova, Anthony E Bishay, Maximilian E Denys, et al.
Plos One|October 1, 2014
Synthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell linesHosadurga K Keerthy, Manoj Garg, Chakrabhavi D Mohan, et al.
Biomolecules|December 19, 2019
The IκB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma CellsJong Hyun Lee, Chakrabhavi Dhananjaya Mohan, Salundi Basappa, et al.
Clinical Drug Investigation|September 30, 2018
Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world EvidenceSara Nazha, Simon Tanguay, Anil Kapoor, et al.
Heliyon|May 19, 2020
ACLY is the novel signaling target of PIP2/PIP3 and Lyn in acute myeloid leukemiaJohnvesly Basappa, Mevlut Citir, Qian Zhang, et al.
Pageof 47